Sign in

Oxford-Harrington Rare Disease Centre

@oxfordharrington.bsky.social
106 followers 49 following 114 posts

Partnership of the University of Oxford and Harrington Discovery Institute. Combining expertise in discovery science and therapeutics development to accelerate cures for rare diseases. Visit us at: www.oxfordharrington.org

PostsRepliesMedia
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 01/10/2026
Delighted to join the MRC CoRE – Therapeutic Genomics annual meeting🧬 A highlight was hearing from people living with rare diseases about their experiences of diagnosis and clinical trials. #TherapeuticGenomics #RareDisease #GeneticMedicine
101
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 25/09/2026
On 25th of September, International Ataxia Awareness Day, we at the Oxford-Harrington Rare Disease Centre stand together with the global Ataxia community on the path towards developing innovative therapeutic approaches.
111
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 23/09/2026
Progress in rare disease starts with people coming together. We're delighted to welcome the rare disease community to the Oxford-Harrington Rare Disease Centre Symposium 2026 for two days of collaboration, shared learning and new ideas. #RareDisease
031
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 22/09/2026
Hope, determination and collaboration. Our new video featuring Genie and her family, alongside Dr Joseph Buxbaum's work in ADNP syndrome, highlights what can happen when families, researchers and clinicians come together to drive progress. buff.ly/HLHCZxQ #RareDisease
buff.ly
Advancing Treatments for ADNP Syndrome Through the Oxford-Harrington Rare Disease Centre
Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.
010
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 17/09/2026
We're delighted to have contributed to the Future for Rare Summit in London. As the UK Rare Diseases Framework approaches its conclusion, it was an important opportunity to help shape what comes next for the rare disease community. #RareDisease #RareDiseaseFramework
011
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 11/09/2026
Scientists have created the largest molecular map of autism to date, identifying 1,800+ protein interactions involving 250+ autism-associated genes. The research could help identify shared pathways — and potential therapeutic targets across multiple genetic forms of autism. 🔗 buff.ly/CA8mHoK
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 02/09/2026
For generations, Bonnie Woolston’s family lived with a rare, unnamed motor neuron disease. Today, we know it as ALS4. 2025 Oxford-Harrington Rare Disease Scholar Albert La Spada, MD, PhD, is advancing RNA-based research towards a potential disease-modifying therapy. Read more: buff.ly/iPKsVmR
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 22/07/2026
We're delighted to be included on Raremap, a new guide to the UK's rare disease research ecosystem developed by @lifearc.bsky.social and @rdrukhub.bsky.social. Explore: 🔗 : buff.ly/yQx6pYT #RareDiseases #RareDiseaseResearch
130
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 16/07/2026
🧬 #RareDiseaseNews Newborn screening for #SpinalMuscularAtrophy (#SMA) will begin rolling out across England from October 2026, helping babies access diagnosis and treatment before symptoms appear. A significant step forward for early diagnosis and #raredisease care. buff.ly/xowFgpj
010
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 15/07/2026
Today is #CASKAwarenessDay. When Sarah was diagnosed with a rare CASK-related disorder, her family was told there were no disease-modifying treatments. Her mother Laura founded @caskresearch.bsky.social to bring awareness and hope to the CASK community. buff.ly/LQO4J9A
110
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 08/07/2026
We welcome the UK government's announcement that the National Institute for Health and Care Research (NIHR) has joined the European Rare Diseases Research Alliance (ERDERA). Read more: buff.ly/mDuFotc #RareDisease #RareDiseaseResearch #ERDERA
100
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 03/07/2026
Great to be part of #GERS2026 last week. At the Genomics England Research Summit, OHC Genomics Lead, Stephan Sanders shared how the MRC CoRE in Therapeutic Genomics and partners are building new pathways to accelerate genetic medicines.
110
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 01/07/2026
We're pleased to welcome Professor Isidro Cortés Ciriano isidrolauscher.bsky.social as the first Little Princess Trust Professor of Paediatric Oncology at @ox.ac.uk, @paediatrics.ox.ac.uk and Cancer Theme Lead at the OHC! Read more: buff.ly/Sg5mWou #RareDisease #ChildhoodCancerResearch
110
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 24/06/2026
As a founding partner, we welcome the announcement that the Rare Therapies Launch Pad (#RTLP) will become part of @lifearc.bsky.social in a bid to accelerate the development and access of individualised medicines for people living with rare diseases. Read more🔗: buff.ly/tfadvK6
010
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 19/06/2026
At the Rare Diseases Network Event at Brunel University London, members of the FA Alliance at Oxford shared updates from six philanthropically funded projects focused on developing new therapeutic approaches for #FriedreichsAtaxia. @ox.ac.uk @kavli.ox.ac.uk
100
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 09/06/2026
Stay up to date with the latest news from the Oxford-Harrington Rare Disease Centre (OHC). Our quarterly newsletter includes science news, programme updates, event announcements, and highlights from across the OHC community. Subscribe to our mailing list: buff.ly/khXMpAl
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 04/06/2026
As highlighted by Brandon Carrus in his discussion with the Chair of the Oxford-Harrington Advisory Council, David Cameron, scientific breakthroughs only change lives when they reach patients. 🔗 buff.ly/nLZmtdI #RareDisease #OxfordHarrington
100
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 29/05/2026
🧬 We're pleased to share Genes, Brains, and Breakthroughs, a new educational animation series helping make topics like #genetics, #neurodevelopmentaldisorders, #rarediseases, and emerging therapies more accessible. 🔗 www.youtube.com/@genebrainbr...
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 26/05/2026
We welcome the @mhragovuk.bsky.social landmark plans to accelerate the development and approval of treatments for rare diseases. For the 3.5M people in the UK living with a rare condition, many without an approved treatment, faster pathways for innovative therapies could be transformative.
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 07/05/2026
We are proud to share a transformational $10M investment from Dee and Jimmy Haslam to accelerate research and drug development for chronic lymphocytic leukaemia (CLL) and other rare blood cancers through the Oxford-Harrington Rare Disease Centre. Read more: tinyurl.com/y6nwj5b2
tinyurl.com
Dee and Jimmy Haslam Make $10 Million Transformational Investment in Blood Cancer Research and Treatments at the Oxford-Harrington Rare Disease Centre
The Oxford-Harrington Rare Disease Centre has received $10 million in transformational support from Dee and Jimmy Haslam to fuel research and drug development for chronic lymphocytic leukaemia (CLL)
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 28/04/2026
At the @rdrukhub.bsky.social 3rd Annual Conference, the theme “The Power of Collaboration,” emphasised how partnerships between organisations - @lifearc.bsky.social, @geneticallianceuk.bsky.social, patients and carers, can build a stronger rare disease ecosystem for #RareDisease drug development.
021
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 22/04/2026
This weekend, Oxford’s “Plodding Professor” takes on the London Marathon for Cure DHDDS to help raise awareness for an ultra‑rare neurological disorder, with wider research implications for conditions such as Parkinson’s and Alzheimer’s. Good luck, Prof Edwards! justgiving.com/page/ploddin...
justgiving.com
Plodding Professor for Cure DHDDS (@ploddingprofessor)
Help James Edwards raise money to support Cure DHDDS
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 17/04/2026
This #AutismAwarenessMonth, we’re highlighting research at OHC advancing new approaches to neurodevelopmental disorders. Work led by OHC Co-Director Matthew Anderson is helping define the biological mechanisms underlying autism to enable more precise, targeted therapeutic strategies. #Neuroscience
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 10/04/2026
As an Oxford-Harrington Rare Disease Scholar, Dr. Jacquelyn Bower is developing an AAV gene therapy for uveal melanoma, a rare eye cancer that often leads to blindness. Her approach targets a key mutation driving tumor survival, with potential to extend life and preserve vision.
010
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 02/04/2026
Last week, at the LifeArc Centre for Rare Respiratory Diseases event, our Director and CSO, Prof Matthew Wood, joined Volker Straub and Jason Mellad, in a panel chaired by Samantha Walker, to discuss how to accelerate the path from rare disease drug discovery to patient impact.
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 25/03/2026
Progress in rare disease research takes more than innovation—it takes shared urgency. OHC Scholar Prof Carlo Rinaldi is developing a novel RNA-based therapy for SBMA while working closely with a team that helps drive ideas forward and accelerate impact. #RareDisease
021
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 19/03/2026
We’re delighted that OHC Co-Director Matthew Anderson has been appointed Visiting Professor at @ox.ac.uk A leader in neuroscience, genetics & therapeutics, he’ll help drive collaboration, mentorship, and innovation in rare disease research. 🔗Read more: tinyurl.com/4zht96ry
tinyurl.com
Matthew Anderson, MD, PhD, OHC Co-Director, Appointed Visiting Professor at the University of Oxford
The University of Oxford has appointed Matthew P. Anderson, MD, PhD, as a Visiting Professor in its Department of Paediatrics—an honor that reflects both his scientific accomplishments and his
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 17/03/2026
Friedreich’s ataxia research is entering a new era. As @BioCentury highlights, the field is shifting toward targeting the root cause of disease — restoring FXN. At the OHC, we’re supporting Oxford-led research through the FA Alliance Innovation Fund. 🔗 Read more: tinyurl.com/2j5v3emn
tinyurl.com
Rare disease spotlight: Friedreich ataxia moves beyond mitochondrial bandages
Friedreich ataxia is moving into a mechanistic second act, as biotechs pivot from stabilizing the mitochondrial damage caused by frataxin loss to developin...
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 10/03/2026
For Rare Disease Day 2026, Genetic Alliance UK brought together patients and stakeholders, including Rare Disease Research UK, Oxford-Harrington Rare Disease Centre, LifeArc, Medical Research Council and many others, at a UK parliamentary reception to raise awareness.
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 05/03/2026
Rare diseases affect an estimated 500 million people worldwide (1 in 17). Yet around 95% of 10,000+ known rare diseases have no approved treatment. In Beyond Biotech by Labiotech.eu, Professor Matthew Wood discusses scalable antisense and gene editing approaches. 🔗 Listen: tinyurl.com/cbxr5vdm
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 04/03/2026
Closing Soon: Oxford-Harrington Rare Disease Scholar Award 2026 Independent academic researchers in the UK, US & Canada can apply for £100K/$100K over two years, plus dedicated drug development support for rare diseases. Deadline: 9 March 2026. 🔗 : tinyurl.com/mr3k3tu9
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 27/02/2026
#RareDiseaseDay, marked each year on the last day of February, shines a light on the 500 million people worldwide living with a rare condition. To mark the day, the OHC illuminated @magdalenoxford.bsky.social in the colours of @rarediseaseday.bsky.social as part of the global #LightUpForRare
141
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 26/02/2026
Thank you to RARE Revolution Magazine® for spotlighting our work to turn scientific discoveries into real medicines for rare diseases. Read more: tinyurl.com/eyfrudcx
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 18/02/2026
With less than one month to go until the 9 March deadline, this is your reminder to apply for the Oxford-Harrington Rare Disease Scholar Award 2026. £100K/$100K in funding + drug development support for academic researchers in the UK, US & Canada. 🔗 tinyurl.com/mr3k3tu9
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 16/02/2026
Rare diseases affect an estimated 500M people worldwide, yet approximately 95% still have no approved treatment. As we look ahead to Rare Disease Day on February 28th, we stand with the rare disease community and reaffirm our commitment to turning breakthrough science into life-changing medicine.
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 09/02/2026
The Oxford-Harrington Rare Disease Centre has awarded philanthropic funding of £500,000 through the FA Alliance Innovation Fund to support five Oxford researchers advancing new therapeutic approaches for Friedreich’s Ataxia, a devastating rare disease with no cure. Read more: tinyurl.com/4srwmjza
tinyurl.com
The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)
The Oxford-Harrington Rare Disease Centre (‘OHC’) dedicated to creating new medicines for rare diseases, today announced that the FA Alliance Innovation Fund has awarded funding to five researchers
011
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 02/02/2026
The next VITALS session will feature Matthew Anderson, MD, PhD, a global leader in rare disease innovation and translational science. He is the co-director of the Oxford-Harrington Rare Disease Centre, with groundbreaking work spanning academia and industry. Register: tinyurl.com/f534nvw4
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 15/01/2026
The Oxford-Harrington Rare Disease Centre invites proposals for its 2026 Rare Disease Scholar Award, supporting the development of innovative therapies for rare diseases. Submissions close on March 9, 2026. Learn more: tinyurl.com/3ynf6xt7
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 12/01/2026
In a recent episode of RARECast, Matthew Wood, Director and CSO of the OHC, discusses the challenges of rare disease drug development, the resources the OHC brings to address them, and the mechanisms established to help accelerate therapeutic development. Listen now: art19.com/shows/rareca...
art19.com
Bridging the Valley for Rare Disease Drug Development
​The Oxford-Harrington Rare Disease Centre represents a transatlantic alliance created to bridge academic research and drug development for rare diseases. Founded in 2019 by the United Kingdom’s…
010
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 05/01/2026
In a recent episode of the In Vivo podcast, Matthew Wood discusses why rare disease research and drug development are at a pivotal moment and what must change to unlock progress for the ~500 million people impacted by rare diseases. 🎧Listen now: shorturl.at/y88MR #RareDiseases #DrugDevelopment
insights.citeline.com
Podcast: “We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation
Matthew Wood, director and chief scientific officer at Oxford-Harrington Rare Disease Center, discusses the state of rare disease R&D, the evolving landscape of genomics and genetic therapies, and…
021
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 19/12/2025
As the year draws to a close, we are grateful to our Scholars, partners and Advisory Council members for their continued commitment to advancing treatments and cures for rare diseases.
110
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 15/12/2025
Last week, the Oxford-Harrington Rare Disease Centre convened its Advisory Council in Oxford to reflect on a year of progress and to set priorities for 2026. Read more: tinyurl.com/5c2kwcny
100
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 28/11/2025
A special seminar on the human impact of ultra-rare diseases—and the growing momentum behind Cure DHDDS —takes place next Tuesday, 2 Dec (2:30–3:30pm) at the Botnar Research Centre, Oxford. 🔹 Melanie Dixon (CureDHDDS) 🔹 Prof. Emyr Lloyd-Evans (Cardiff University) 🔗 talks.ox.ac.uk/talks/id/b90...
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 20/11/2025
Today, we are pleased to announce the 10 outstanding scientists selected for the 2025 Rare Disease Scholar Award, who will drive scientific breakthroughs to transform treatment options for the 500M people worldwide affected by rare diseases. Read more: tinyurl.com/49baysns
An academic researcher looking into a microscope
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 18/11/2025
Earlier in November, the OHC team joined the programme and conversations at the CamRare Summit 2025, exploring how scientific advances, policy shifts and new models of collaboration could shape the next decade of rare disease research and care. Photos: Jeremy Peters #RAREsummit25
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 14/11/2025
Earlier this week, Prof Matthew Wood, OHC Director, spoke at the FT Live Global Pharma & Biotech Summit. He said: "It was valuable to highlight the essential role of academic drug development in addressing rare diseases and the importance of regulatory innovation."
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 07/11/2025
Yesterday, we heard from Professor Carlo Rinaldi, Neurological Disorders Theme Lead at the Oxford-Harrington Rare Disease Centre, who spoke at the Cambridge Rare Disease Network (CamRARE) Rare Summit 2025 about the next decade of rare disease innovation.
010
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 03/11/2025
MHRA reforms mark a vital step toward faster, safer innovation for the 500M people worldwide living with rare diseases. A more adaptive, evidence-based framework will help researchers and clinicians deliver life-changing therapies faster. Read more: tinyurl.com/msurx5ju
tinyurl.com
New drugs to be approved faster so patients don’t wait years
The medicines watchdog is changing how it oversees research of 7,000 rare diseases, which collectively affect about one in 17 Britons
021
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 31/10/2025
Every breakthrough starts with a bold idea—and the support to make it real. Join the Oxford-Harrington Rare Disease Centre webinar to hear how scientists & philanthropists are working together to advance cures for the world’s rarest diseases. 🔗 www.harringtondiscovery.org/events
harringtondiscovery.org
Events Calendar for Harrington Discovery Institute | Harrington Discovery Institute at University Hospitals
Upcoming and past events for Harrington Discovery Institute showcasing how grant funding accelerates science into medicines for diseases, social impact fundraising
000
Oxford-Harrington Rare Disease Centre @oxfordharrington.bsky.social · 27/10/2025
Professor Matthew Wood, Director of the Oxford-Harrington Centre, joins the FT Live Global Pharma and Biotech Summit to explore the future of healthcare innovation. 📅 11–12 Nov | London & online 🔗 bit.ly/4pPcJpd #FTPharma #Biotech
000